GraftBio™ SNEDDS platform
Graft Polymer’s novel and patented micelle technology encapsulate the particular substances in the tiniest, completely homogeneous individual parts in the shape of product micelles. Important agents are no longer discharged broadly unused but release their complete and planned effect by making active agents water-soluble.
The described method clears a particular potential in both the nutritional supplement and pharmaceutical market.
The self-nano emulsifying drug delivery system (SNEDDS) contains all API components as the lipophilic core of a micelle and emulsifiers/co-solvent and stabilizer excipients as a micelle shell in the aqueous phase, with a globular micelle size below 50 nm.